Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
about
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymomaBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveMicroarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3Molecular genetics of ependymomaIntegrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseDelineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumorsHistopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence.Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.Prognosis-related molecular markers in pediatric central nervous system tumors.Advances in the treatment of pediatric brain tumors.Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysisMolecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsDistinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.Pediatric CNS tumors: current treatment and future directions.Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymomaMolecular neuropathology of gliomas.The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomasPediatric neuro-oncology: current status and future directions.Emerging insights into the ependymoma epigenome.Pediatric Ependymoma.Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.Evaluation of chromosome 1q gain in intracranial ependymomas.Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.Nestin expression identifies ependymoma patients with poor outcome.Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients.Chromosomal imbalances in clear cell ependymomas.Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas.Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
P2860
Q24652909-40A6F1DC-E212-4F51-BDDF-08096EFE60EFQ24658389-44C37681-2247-47AE-90FA-1F55E67D5B9CQ24683906-60C79DDF-F409-4008-A5D1-5D93DA3E7C9CQ30438459-3E3D9C2D-13F5-4EDB-B167-0DA97C9F52CFQ33803137-BD31BA18-7C88-43BF-B1E8-7A28348A80F5Q33990951-B863F01F-AE18-4231-BC6D-FD7D29591BE2Q34132926-85B6B48D-4075-4062-8074-5EB48932E0D4Q34166553-C714ECDA-4EFD-4943-BDBA-6C916B4D0CC7Q35053098-F00500C0-4E1B-4D09-AE93-3D97417D07E0Q35748208-36C0F8EC-1E69-408C-9BA7-33AA090CF99FQ35805725-2110095F-5415-4807-ACD8-30BF9776BE39Q35945392-F004AEF3-6E0A-491E-ADE1-2C409CA4D8C1Q35996275-9F254943-C187-4C47-971F-E7C709B0A254Q36106882-D5D4A88D-2E38-44EA-8758-7C7ABAB3422BQ36344765-355A3B7A-B7DB-4D48-883C-351338CD10F7Q36461766-35EFE0DD-E97C-4D4B-9C87-3B719B5CB86BQ36560149-96AC4AFB-2918-40A1-BEED-253E5FA94654Q36902043-4DBB8FDE-7E39-45FF-9128-AB352C32F432Q37196135-E36E0C12-88AA-4C60-AE24-8FD601955283Q37427424-35D94900-973F-42EF-9979-D22626E9B695Q37553466-DD51AEBB-E8C1-4228-8D7B-72C9B771114BQ37727557-5275E61D-76CA-4800-B697-92F835F5D272Q38003799-539AE885-95FF-4EAB-947A-6746122DB1C9Q38035070-ADD52C39-FB53-492D-AB34-638EC05806D3Q38083798-194B7DFE-288C-49DE-9ACB-75D1CFB7719CQ38616800-76E48A8D-C082-43CE-B1CB-4CDF7B0CDB7FQ38653412-0B6CE1D9-ABD5-459F-B804-1745EE05004BQ38681915-658994E8-CAAB-44FF-A26B-8368366A2AD0Q39316156-6810141F-FDC1-4AE9-A423-AC1346855785Q39459076-F0B2D894-1ABF-48EC-BF7E-71848C6D5461Q40150706-AAE1F2FA-01FC-4C7E-B54A-2FCBEEF123C9Q42129591-70EA730B-F8E4-436F-B8B8-B04556CA0078Q43662312-7C7A380E-3AB8-4506-9C09-DFE4734D54BAQ44949318-E8C7CD6C-93A5-4BD6-91D3-83B6D4650854Q48136404-DDAF6132-6A50-493C-9EDA-D72A759F3624Q54353008-5F644846-C040-406E-AEB1-90F654CDDD69Q55470168-EBB7BBD6-554F-4435-B045-401180BF837FQ55472537-FB8A7DEF-71C3-4A83-A326-AA6C3B5BE9B1Q57652291-AF5347FA-B3E9-456C-8236-6975C534482A
P2860
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@ast
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@en
type
label
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@ast
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@en
prefLabel
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@ast
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@en
P2093
P2860
P356
P1476
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
@en
P2093
D W Ellison
J Nicholson
R Allibone
R Gilbertson
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600180
P407
P577
2002-03-01T00:00:00Z
P5875
P6179
1001989695